Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/08/2010 | US7732420 Combinations of transfection lipids exhibiting increased transfection efficiencies |
06/08/2010 | US7732415 Topical treatment or prevention of ocular infections |
06/08/2010 | US7732411 Methods of therapy with thrombin derived peptides |
06/08/2010 | US7732399 complexes composed of a protein or peptide and a gallic acid ester that allow for sustained delivery of the protein or peptide in vivo upon administration of the complex; gallic acid ester is epigallocatechin gallate; for drug delivery |
06/08/2010 | US7732190 Mixture comprising a first functionalized polymer in a first buffer; a second buffer at approximately physiological osmolality; a second functionalized polymer, a substance having at least one cell-adhesion site combined with the first mixture |
06/08/2010 | US7732015 Low cost equipment, high speed manufacturing; uniform particle size; covering openings of micropores |
06/08/2010 | US7731991 Non-food and non-pharmaceutical use of a selected anhydrous dextrose composition |
06/08/2010 | US7731990 Powdery composition for nasal administration |
06/08/2010 | US7731989 Gastric retained gabapentin dosage form |
06/08/2010 | US7731986 comprises a sclerosant liquid, e.g. polidocanol solution, and a gas e.g. O2 or CO2; by inter alia causing a localised inflammatory reaction, favor the elimination of varicose veins and other disorders involving venous malformation |
06/08/2010 | US7731983 Method and composition for the treatment of scars |
06/08/2010 | US7731981 surgical injection of dehydrated particles or a gel or suspension into the joint; mixtures may also include radiocontrast materials, analgesics, antibiotics, proteoglycans, growth factors, and other cells to promote healing and proper joint function |
06/08/2010 | US7731968 Topical delivery of vaccines |
06/08/2010 | US7731954 Wound dressings comprising hydrated hydrogels and enzymes |
06/08/2010 | US7731944 Hair cosmetic compositions |
06/08/2010 | US7731790 Composition comprising a liquid absorbed on a support based on precipitated silica |
06/08/2010 | US7731758 Implant for subcutaneous or intradermal injection |
06/08/2010 | CA2602037C Indicator for orally administered compositions |
06/08/2010 | CA2506712C Rapidly-decomposing administrable form for releasing ingredients in the oral cavity or in bodily cavities |
06/08/2010 | CA2447178C Pharmaceutical composition for use in hormone replacement therapy |
06/08/2010 | CA2442281C Intravaginal drug delivery devices for the administration of an antimicrobial agent |
06/08/2010 | CA2434972C Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
06/08/2010 | CA2386547C Orally disintegrating composition comprising mirtazapine |
06/08/2010 | CA2383233C Surface modified particulate compositions of biologically active substances |
06/08/2010 | CA2379210C Composition for enteral nutrition containing fibre |
06/08/2010 | CA2370019C Transdermal therapeutic system with neutralized acrylic pressure-sensitive adhesives |
06/08/2010 | CA2369300C Water-soluble compositions of bioactive lipophilic compounds |
06/08/2010 | CA2360590C Solution-based transdermal drug delivery system |
06/08/2010 | CA2283684C Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides |
06/08/2010 | CA2199516C Needle-less parenteral introduction device |
06/03/2010 | WO2010062996A2 Ribavirin composition |
06/03/2010 | WO2010062835A1 Antioxidant compositions for soft oral tissue and methods of formulation and use there |
06/03/2010 | WO2010062824A2 Enhanced bioactive formulations of resveratrol |
06/03/2010 | WO2010062688A2 Dosage form for insertion into the mouth |
06/03/2010 | WO2010062678A2 Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same |
06/03/2010 | WO2010062628A1 Compositions and methods for treating asthma and other lung disorders |
06/03/2010 | WO2010062570A2 COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE |
06/03/2010 | WO2010062561A1 Advanced nanomaterials for regulating specific cell functions |
06/03/2010 | WO2010062524A1 Extended release oral acetaminophen/tramadol dosage form |
06/03/2010 | WO2010062523A2 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
06/03/2010 | WO2010062413A1 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
06/03/2010 | WO2010062394A2 Implantable ocular drug delivery device and methods |
06/03/2010 | WO2010062322A2 Modulation of the immune response |
06/03/2010 | WO2010062261A1 System and method for preparing a controlled releas preparation |
06/03/2010 | WO2010062221A1 Substituted 2-(5-hydroxy-2-methyl-1n-indole-3-il) acetic acids and ethers thereof and the use of same to treat viral diseases |
06/03/2010 | WO2010062191A1 Improved bolus |
06/03/2010 | WO2010062190A1 Improvements in bolus devices for the delivery of active agents to animals |
06/03/2010 | WO2010062147A2 Crystal form of adefovir dipivoxil, preparation method thereof, and pharmaceutical composition containing the same |
06/03/2010 | WO2010061924A1 Avian influenza vaccine |
06/03/2010 | WO2010061921A1 Method for stabilizing l-ascorbic acid, liquid extraction preparation, solid extract, and semi-fluid extract |
06/03/2010 | WO2010061919A1 Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof |
06/03/2010 | WO2010061880A1 Vesicle preparation |
06/03/2010 | WO2010061846A1 Orally rapidly disintegrating tablet, and process for producing same |
06/03/2010 | WO2010061386A2 Pharmaceutical composition and system for permeabilizing fetal membranes |
06/03/2010 | WO2010061330A1 Methods for inhibiting gram-positive bacteria using non-phospholipid lipid vesicules |
06/03/2010 | WO2010061193A2 Compositions with reduced dimer formation |
06/03/2010 | WO2010061147A1 Carrier in oil-in-water emulsion form, particularly for cosmetic or dermatological use |
06/03/2010 | WO2010060989A1 Solution of lipophilic substances, especially medicinal solutions |
06/03/2010 | WO2010060958A1 Controlled release pharmaceutical compositions comprising o-desmethyl-venlafaxine |
06/03/2010 | WO2010060886A2 Mouthwash in the form of a stable suspension comprising microspheres that incorporate an active ingredient |
06/03/2010 | WO2010060875A1 Novel powdered crystalline medicines for inhalation |
06/03/2010 | WO2010060811A2 Surface active proteins as excipients in solid pharmaceutical formulations |
06/03/2010 | WO2010060798A1 Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester |
06/03/2010 | WO2010060667A1 Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides |
06/03/2010 | WO2010060635A2 Solid pharmaceutical composition comprising at least one stabilizing agent |
06/03/2010 | WO2010060624A2 Dry processing and novel forms of lacosamide |
06/03/2010 | WO2010060621A1 Polyurethane plaster for the transdermal application of active substances, and method for the production thereof |
06/03/2010 | WO2010060564A1 Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-ii antagonist and/or a diuretic |
06/03/2010 | WO2010060529A1 Microparticles comprising a salt of 8-hydroxy-2- [ [ ( ir) -2- (4-methoxyphenyl) -l-methylethyl] aminol ethyll -2 (ih) -quinolin one |
06/03/2010 | WO2010060200A1 Bacteriophage compositions for treatment of bacterial infections |
06/03/2010 | WO2010060190A1 Plant extract compositions for affecting sleep |
06/03/2010 | WO2010041017A3 Chewable gelled emulsions |
06/03/2010 | WO2010035226A3 Herbal composition and method for the treatment of viral infection |
06/03/2010 | WO2010030598A3 Pharmaceutical formulations comprising pemetrexed |
06/03/2010 | WO2010027498A3 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes emillitus, pre-diabetic symptoms, insulin resistance and related disease states and conditions |
06/03/2010 | WO2010023690A3 Prolonged release formulation of amisulpride |
06/03/2010 | WO2010021607A3 Pharmaceutical formulation |
06/03/2010 | WO2010020856A3 Rate modulated delivery of drugs from a composite delivery system |
06/03/2010 | WO2010019266A3 Linaclotide-containing formulations for oral administration |
06/03/2010 | WO2010009056A3 Pain relieving patch |
06/03/2010 | WO2009121935A3 Pharmaceutical composition with bisphosphonate |
06/03/2010 | WO2009087632A3 Emulsified wax compositions and uses thereof |
06/03/2010 | US20100137975 Active-substance-coated medical product, method for its production and its uses |
06/03/2010 | US20100137940 Method for Directed Intranasal Administration of a Composition |
06/03/2010 | US20100137844 Delivery devices for modulating inflammation |
06/03/2010 | US20100137843 Delivery devices for modulating inflammation |
06/03/2010 | US20100137842 Ambulatory Infusion Devices With Improved Delivery Accuracy |
06/03/2010 | US20100137696 Medical device with reservoir-based sensors |
06/03/2010 | US20100137512 Polyethylene glycol/polycation block copolymers |
06/03/2010 | US20100137427 Softgel of NLKJ for treating prostate diseases |
06/03/2010 | US20100137418 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent |
06/03/2010 | US20100137352 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
06/03/2010 | US20100137304 Novel crystalline forms of the anti-cancer compound zd1839 |
06/03/2010 | US20100137271 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
06/03/2010 | US20100137232 Composition comprising a diuretic and a cardiac glycoside for the treatment of dna viral infections of the eye |
06/03/2010 | US20100137198 Pharmaceutical composition for topical application |
06/03/2010 | US20100136130 Preparation for the Controlled Release of Bioactive Natural Substances |
06/03/2010 | US20100136129 Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof |
06/03/2010 | US20100136128 Odor control fragrance additive |
06/03/2010 | US20100136127 Solid preparation comprising alogliptin and metformin hydrochloride |